logo
15:59 Feb 25

Marksans Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
175.86
+1.79 (+1.03%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Marksans Pharma Ltd. Financials

Marksans Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
175.86
+1.79 (+1.03%)
15:59 Feb 25
Quality
image/svg+xml

57/100
High Financial Strength

Valuation
image/svg+xml

35/100
Mid Valuation

Technical

41/100
Technically Neutral

Strength

7

Weakness

3

Opportunity

0

Threats

0

15.42 %

ROE %

11.74 %

ROA %

7.95

EPS

54.44

BVPS

14.51 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
1490.84 1852.14 2177.41 2622.84 2803.29
Operating Expenses +
1231.95 1512.82 1718.83 2094.2 2272.15
Raw Material
703.92 927.75 1111.98 1327.5 1347.95
Increase Decrease in Cost
12.9 -6.39 -73.86 -183.76 -136.11
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
220.3 239.37 293.64 350.3 411.39
Miscellaneous Expenses
621.33 981.65 1275.63 1749.12 648.92
Operating Profit
258.89 339.32 458.58 528.64 531.14
Other Income
41.85 59.31 50.42 70.38 63.87
Depreciation
44.78 51.85 74.27 83.39 97.09
Interest
8.45 9.13 11.2 11.66 21.26
Profit before tax and exceptio..
247.51 337.65 423.53 503.97 476.66
Exceptional Items
0 0 0 0 0
PBT
247.51 337.65 423.53 503.97 476.66
Provision for Taxation
60.7 72.33 108.63 121.35 114.9
Net Profit
186.81 265.32 314.9 382.62 361.76
NET Profit after MI
186.81 266.31 313.7 380.58 360.32
EPS
4.51 6.41 6.92 8.4 7.96
Operating Profit Margin (%)
17.37 18.32 21.06 20.16 18.95
Net Profit Margin (%)
12.53 14.38 14.41 14.51 12.85

Marksans Pharma Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 43.90 43.90 43.90 43.90 43.90 43.90
FII 8.10 16.90 19.90 22.20 22.00 21.30
Public 5.90 5.30 5.50 4.50 4.20 4.10
Others 42.10 33.90 30.70 29.40 29.90 30.70
Shareholder Shares Holding %
Research 360 logo
Download Our App On: